Survival of patients with a new diagnosis of heart failure: A population based study

Heart

Volumn 83, Issue 5, 2000, Pages 505-510

  Cowie, M R ^a   Wood, D A ^a   Coats, A J S ^a   Thompson, S G ^b   Suresh, V ^a   Poole Wilson, P A ^a   Sutton, G C ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Epidemiology; Heart failure; Prognosis; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE;

EID: 0034024566     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.5.505     Document Type: Article

References (40)

1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative north Scandinavian enalapril survival study (CONSENSUS). N Engl J Med 1987;316:1429-35.
2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
3. Eriksson H. Heart failure: a growing public health problem. J Intern Med 1995;237:135-41.
4. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993;22:6-13A.
5. Cohn JN, Johnson GR, Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993;87:VI-5-16.
6. Campana C, Gavazzi A, Berzuini C, et al. Predictors of prognosis in patients awaiting heart transplantation. J Heart Lung Transplant 1993;12:756-65.
7. Aaronson KD, Schwartz JS, Chen T-M, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660-7.
8. Cowie MR, Wood DA, Coats A, et al. Incidence and aetiology of heart failure: a population-based study. Eur Heart J 1999;20:421-8.
9. Sahn DJ, DeMaria A, Kisslo J, et al. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiographic measurements. Circulation 1978;58:1072-82.
10. Henry WL, DeMaria A, Gramiak R, et al. Report of the American Society of Echocardiography committee on nomenclature and standards in two-dimensional echocardiography. Circulation 1980; 62:212-17.
11. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-15.
12. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995;16:741-51.
13. World Health Organisation. Manual of the international statistical classification of diseases, injuries and causes of death. Geneva: WHO, 1977.
14. Office for National Statistics. Mortality statistics: cause. Review of the Registrar General on deaths by cause, sex and age, in England and Wales, 1995. DH2 No 22. London: HMSO, 1997:176-9.
15. Collett D. Modelling survival data in medical research. London: Chapman and Hall, 1994.
16. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
17. CIBIS-II Investigators and Committee. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
18. Rodeheffer RJ, Jacobsen SJ, Gersh BJ, et al. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 1993;68:1143-50.
19. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98:2282-9.
20. Eriksson H, Caidahl K, Larsson B, et al. Cardiac and pulmonary causes of dyspnoea - validation of a scoring test for clinical-epidemiological use: the study of men born in 1913. Eur Heart J 1987;8:1007-14.
21. Massie BM, Conway M. Survival of patients with congestive heart failure: past, present, and future prospects. Circulation 1987;75:11-19.
22. Fuster V, Gersh BJ, Giuliani ER, et al. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981;47: 525-31.
23. Lee TH, Hamilton MA, Stevenson LW, et al. Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 1993;76:672-6.
24. Unverferth DV, Magorien RD, Moeschberger ML, et al. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1984;54:147-52.
25. Szlachcic J, Massie BM, Kramer BL, et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985;55:1037-42.
26. Kelly TL, Cremo R, Nielsen C, et al. Prediction of outcome in late-stage cardiomyopathy. Am Heart J 1990;119:1111-21.
27. Parameshwar J, Keegan J, Sparrow J, et al. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992; 123:421-6.
28. Scrutinio D, Lagioia R, Ricci A, et al. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. Eur Heart J 1994;15:1089-95.
29. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991;84:40-8.
30. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73:257-67.
31. Johnson RA, Palacios I. Dilated cardiomyopathies of the adult. N Engl J Med 1982;307:1051-8.
32. Demakis JG, Proskey A, Rahimtoola SH, et al. The natural course of alcoholic cardiomyopathy. Ann Intern Med 1974; 80:293-7.
33. Kuhn H, Becker R, Fischer J, et al. Studies on the etiology, the clinical course and the prognosis of patients with dilated cardiomyopathy (DCM). Z Kardiol 1982;71:497-508.
34. Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe congestive heart failure: relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 1984; 310:347-52.
35. Hatle L, Orjavik O, Storstein O. Chronic myocardial disease. I. Clinical picture related to long-term prognosis. Acta Med Scand 1976;199:399-405.
36. Cleland JGF, Dargie HJ, Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J 1987;58: 572-82.
37. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989;261:884-8.
38. Kelly TL, Cremo R, Nielsen C, et al. Prediction of outcome in late-stage cardiomyopathy. Am Heart J 1990;119:1111-21.
39. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73:257-67.
40. Cowburn PJ, Cleland JGF, Coats AJS, et al. Risk stratification in chronic heart failure. Eur Heart J 1998;19:696-70.